ReviewJournal of medical case reports2026
S. carcinoma arising in a breast implant: a case report and review of the literature.
Review in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast implants are widely used in plastic surgery and generally considered safe. However, recent reports of implant-associated malignancies, including anaplastic large-cell lymphoma and squamous-cell carcinoma, have raised concern. This report presents a case of squamous-cell carcinoma arising in a silicone breast implant and reviews the current literature on its association with breast implants. CASE PRESENTATION: A 48-year-old Hispanic female presented with pain and asymmetry of the left breast. Persistent symptoms and imaging findings led to the identification of a cystic mass associated with a silicone implant. Histopathological analysis confirmed squamous-cell carcinoma arising from the periprosthetic capsule. The patient underwent implant removal, and after radiologic surveillance and diagnosis of recurrence, an attempted oncoplastic approach was converted intraoperatively to a radical mastectomy due to extensive tumor infiltration. No adjuvant therapy was administered. At 12-month follow-up, the patient remains disease-free without evidence of recurrence.
conclusionsThe diagnosis and management of breast-implant-associated squamous-cell carcinoma require a multidisciplinary approach due to its unpredictable behavior. Increased awareness, early detection, and individualized treatment strategies are essential to improve outcomes in this rare but aggressive entity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.